Table 3 of
Hayashida, Mol Vis 2020; 26:505-509.
Table 3. Clinical outcomes of cCSC patients according to ARMS2 genotype.
Values are presented as mean ± SD. cCSC, chronic central serous chorioretinopathy; RFPDT, reduced-fluence photodynamic therapy;
BCVA, best-corrected visual acuity; logMAR, logarithmic minimum angle of resolution.
Hayashida, Mol Vis 2020; 26:505-509. http://www.molvis.org/molvis/v26/505
©2020 Molecular Vision